Rezolute, Inc. (RZLT) vs ARS Pharmaceuticals, Inc. (SPRY)
- Rezolute, Inc. RZLT 3.58 −8.21%
- ARS Pharmaceuticals, Inc. SPRY 4.02 −1.23%
Rezolute, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Rezolute, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($404.8M and $377.2M). Rezolute, Inc. has the higher net margin (0.00% vs −184.3%) and the higher return on invested capital (0.00% vs −335.7%). Across the 14 metrics below, Rezolute, Inc. leads on 12 and ARS Pharmaceuticals, Inc. on 2.
Valuation
Profitability
| Metric | RZLT | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 71.37% | 65.16% |
| Operating margin | 0.00% | (184.96%) | 0.00% |
| Net margin | 0.00% | (184.26%) | 0.00% |
| Free cash flow margin | 0.00% | (167.97%) | 0.00% |
| Return on equity | (59.04%) | (210.37%) | (56.36%) |
| Return on assets | (53.82%) | (76.54%) | (48.04%) |
| Return on invested capital | 0.00% | (335.65%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack